InvestorsHub Logo
Followers 98
Posts 11521
Boards Moderated 0
Alias Born 05/29/2014

Re: SPecPrototype post# 9364

Tuesday, 11/20/2018 4:42:15 AM

Tuesday, November 20, 2018 4:42:15 AM

Post# of 52112
"The Company has entered into a new stage of aggressively ramping up its efforts to commercialize the technology through sublicensing and joint venture agreements. Target partners include licensed producers and dealers in the United States, Canada and abroad, as well as pharmaceutical companies focused on cannabinoids therapies."

According to the company's news - "New delivery systems are making their way into the industry. By way of example - the industry is fast adopting similar delivery technologies as seen in recent transactions."

Standardized and controlled dosing is driving cannabis companies strategic direction, and what may been fueling many of these delivery system transactions. This new and innovative U.S. company (OTC: GCAN) is correct and right on the money in not only seeing the trend, but participating in it."


"Patience is bitter, but its fruit is sweet."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GCAN News